Summit Securities Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10
| Closed | -$4.85K | – | 1297 |
|
|
2025
Q1 | $4.85K | Sell |
10
-32
| -76% | -$15.5K | ﹤0.01% | 476 |
|
|
2024
Q4 | $16.9K | Buy |
+42
| New | +$16.9K | ﹤0.01% | 281 |
|
|
2024
Q3 | – | Sell |
-34
| Closed | -$16K | – | 772 |
|
|
2024
Q2 | $16K | Buy |
+34
| New | +$16K | ﹤0.01% | 286 |
|
|
2024
Q1 | – | Sell |
-21
| Closed | -$9K | – | 742 |
|
|
2023
Q4 | $9K | Sell |
21
-8
| -28% | -$3.43K | ﹤0.01% | 329 |
|
|
2023
Q3 | $10K | Sell |
29
-59
| -67% | -$20.3K | ﹤0.01% | 273 |
|
|
2023
Q2 | $31K | Buy |
+88
| New | +$31K | ﹤0.01% | 409 |
|
|
2022
Q4 | – | Sell |
-1,008
| Closed | -$292K | – | 1135 |
|
|
2022
Q3 | $292K | Buy |
+1,008
| New | +$292K | 0.02% | 216 |
|
|
2022
Q2 | – | Sell |
-1,151
| Closed | -$300K | – | 960 |
|
|
2022
Q1 | $300K | Buy |
+1,151
| New | +$300K | 0.03% | 180 |
|
|
2013
Q3 | – | Sell |
-100
| Closed | -$8K | – | 436 |
|
|
2013
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 278 |
|